Brief: Egetis Therapeutics Q2 Loss Narrows To SEK 33.2 Mln
Aug 19 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST :
* Q2 REVENUES MSEK 4.7 (25.0)
* Q2 LOSS MSEK -33.2 (-34.3)
Source text for Eikon: ID:nMFNbS1WWs
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1